Float Short %

0.79

Margin Of Safety %

Put/Call OI Ratio

0.94

EPS Next Q Diff

5.45

EPS Last/This Y

EPS This/Next Y

3.98

Price

69.03

Target Price

98.93

Analyst Recom

2.03

Performance Q

-0.4

Relative Volume

0.74

Beta

0.64

Ticker: NVO

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	NVO	72.82	0.90	0.43	523494
2025-06-03	NVO	70.91	0.89	1.09	530194
2025-06-04	NVO	72.04	0.90	1.25	539403
2025-06-05	NVO	72.56	0.91	4.93	540938
2025-06-06	NVO	74.64	0.95	0.35	555981
2025-06-09	NVO	75.46	0.91	0.72	533733
2025-06-10	NVO	79.33	0.90	0.50	541772
2025-06-11	NVO	78.73	0.89	1.03	558822
2025-06-12	NVO	81.14	0.88	1.00	560380
2025-06-13	NVO	79.85	0.91	0.56	585004
2025-06-16	NVO	77.09	0.87	0.93	557922
2025-06-17	NVO	74.4	0.88	1.17	566186
2025-06-18	NVO	74.01	0.89	1.43	575049
2025-06-20	NVO	73.76	0.89	1.33	579152
2025-06-23	NVO	69.72	0.93	0.47	465680
2025-06-24	NVO	70.73	0.93	0.71	487901
2025-06-25	NVO	67.38	0.93	0.81	497365
2025-06-26	NVO	67.69	0.93	0.40	514674
2025-06-27	NVO	68.55	0.91	1.80	523711
2025-06-30	NVO	69.03	0.94	0.31	508490
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	NVO	72.81	31.8	3247.0	26.09
2025-06-03	NVO	70.91	31.8	2644.9	26.09
2025-06-04	NVO	72.04	31.8	2010.2	26.09
2025-06-05	NVO	72.65	31.8	1712.1	26.09
2025-06-06	NVO	74.66	31.8	2302.8	26.09
2025-06-09	NVO	75.46	31.8	1911.0	26.09
2025-06-10	NVO	79.35	31.8	3051.4	26.09
2025-06-11	NVO	78.72	31.8	1560.1	26.09
2025-06-12	NVO	81.05	31.8	2338.9	26.09
2025-06-13	NVO	79.89	31.8	1907.0	26.03
2025-06-16	NVO	77.02	31.8	1236.5	26.03
2025-06-17	NVO	74.35	31.8	1244.6	26.03
2025-06-18	NVO	74.01	31.8	1590.4	26.03
2025-06-20	NVO	73.77	31.8	1767.5	26.03
2025-06-23	NVO	69.72	31.8	854.3	26.03
2025-06-24	NVO	70.74	-	2352.6	0.00
2025-06-25	NVO	67.34	-	1157.7	0.00
2025-06-26	NVO	67.69	32.7	2147.1	26.13
2025-06-27	NVO	68.51	32.7	2638.0	26.13
2025-06-30	NVO	69.03	32.7	2468.0	26.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	NVO	0	-5.97	0.82
2025-06-03	NVO	0	-5.97	0.82
2025-06-04	NVO	0	-5.97	0.82
2025-06-05	NVO	0	-5.97	0.82
2025-06-06	NVO	0	-5.97	0.82
2025-06-09	NVO	0	-5.87	0.82
2025-06-10	NVO	0	-5.87	0.82
2025-06-11	NVO	0	-5.87	1.00
2025-06-12	NVO	0	-5.87	1.00
2025-06-13	NVO	0	-5.87	1.00
2025-06-16	NVO	0	-4.33	1.00
2025-06-17	NVO	0	-4.33	1.00
2025-06-18	NVO	0	-4.33	1.00
2025-06-20	NVO	0	-4.33	1.00
2025-06-23	NVO	0	-3.84	1.00
2025-06-24	NVO	0	-3.84	1.00
2025-06-25	NVO	0	-3.84	1.00
2025-06-26	NVO	0	-3.84	0.79
2025-06-27	NVO	0	-3.84	0.79
2025-06-30	NVO	0	-4.38	0.79
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.92

Avg. EPS Est. Current Quarter

5.96

Avg. EPS Est. Next Quarter

6.37

Insider Transactions

Institutional Transactions

-4.38

Beta

0.64

Average Sales Estimate Current Quarter

76933

Average Sales Estimate Next Quarter

82202

Fair Value

75.14

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.4

Max Drawdown 5-Year %

-59.7

Target Price

98.93

P/E

20.47

Forward P/E

14.64

PEG

1.09

P/S

5.33

P/B

15.28

P/Free Cash Flow

16.26

EPS

3.37

Average EPS Est. Cur. Y

26.13

EPS Next Y. (Est.)

30.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

34.52

Relative Volume

0.74

Return on Equity vs Sector %

51.7

Return on Equity vs Industry %

43.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.04

EBIT Estimation

2468

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 77406

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y